Gyrate Atrophy of the Choroid and Retina
The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Abstract
Gyrate atrophy of the choroid and retina (GA) is an autosomal recessive chorioretinal degeneration with a 10-20-fold elevation of plasma ornithine due to deficient activity of ornithine aminotransferase. Type II fibres of the skeletal muscle are atrophic and contain tubular aggregates in electron microscopy. Deficient creatine and creatine phosphate formation have been postulated to be involved in the pathogenesis of GA. The five-year follow-up results of oral creatine supplementation in 13 patients are presented. Visual function tests and fundus photographs showed progression of GA during the treatment. The velocity of the progression varied considerably between individuals. Generally, the progression was rapid in the young patients and slow in the more advanced stages. Abnormalities in the skeletal muscle decreased or disappeared rapidly. They reappeared in the few patients who discontinued the medication. The difference in the therapeutic effect on the skeletal muscle and eye is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, long-term, high dose ingestion of creatine (up to 30 g/d for up to 5 years) in patient populations has not been associated with an increased incidence of renal dysfunction [23, 155, 156, 172].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [155]
In the citing paper
“or has long-term detrimental effects [22, 23, 53, 155, 172].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [155]
In the citing paper
“As a result, creatine concentrations in serum, urine, erythrocytes, brain, and muscle are reduced in these patient populations [58,67].”
From Creatine Supplementation in Children and Adolescents (2021) · cites this paper as [58]
In the citing paper
“Creatine supplementation has also been shown to be an effective therapy to treat gyrate atrophy of the retina.”
From Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review (2018) · cites this paper as [29]
In the citing paper
“Vannas-Sulonen et al. (29)reported on 13 patients who ranged in age from 6 to 31 years old. In particular, five patients were < 18 years of age (6–16 years, median: 12 years; 119–174 cm, median: 165 cm, 21–76 kg, median: 56 kg) and were treated with creatine for 40–72 months, median treatment duration: 60 months).”
From Safety of Creatine Supplementation in Active Adolescents and Youth: A Brief Review (2018) · cites this paper as [29]
Citations
Cites
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404
Hereditary diseases in Finland; rare flora in rare soul.
Norio, R., Nevanlinna, H. R., & Perheentupa, J. (1973) · PubMed · Cited by 251
RAISED PLASMA-ORNITHINE AND GYRATE ATROPHY OF THE CHOROID AND RETINA
Simell, O., & Takki, K. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90667-3 · Cited by 251
Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina
Sipilä, I., Rapola, J., Simell, O., & Vannas, A. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104093041503 · Cited by 181
Gyrate atrophy of the choroid and retina associated with hyperornithinaemia.
Takki, K. K. (1974) · British Journal of Ophthalmology · doi:10.1136/bjo.58.1.3 · Cited by 147
Valle, D., Kaiser-Kupfer, M. I., & Valle, L. A. D. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.5159 · Cited by 146
The Natural History of Gyrate Atrophy of the Choroid and Retina
Takki, K. K., & Milton, R. C. (1981) · Ophthalmology · doi:10.1016/s0161-6420(81)35031-3 · Cited by 132
Valle, D. L., Walser, M., Brusilow, S. W., & Kaiser‐Kupfer, M. I. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109680 · Cited by 99
Sipilä, I., Simell, O., Rapola, J., Sainio, K., & Tuuteri, L. (1979) · Neurology · doi:10.1212/wnl.29.7.996 · Cited by 90
Sipilä, I. (1980) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(80)90194-1 · Cited by 87
Research works printed but not linked: 1
- O'Donnell, 1981, Mitochondrial abnormalities in cultured fibroblasts from a gyrate atrophy patient. ARVO Abstracts, Invest Ophthalmol Vis Sci, 20, 79
Cited by
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“Moreover, long-term, high dose ingestion of creatine (up to 30 g/d for up to 5 years) in patient populations has not been associated with an increased incidence of renal dysfunction [23, 155, 156, 172].”
BackgroundLong-term creatine intake is beneficial to muscle performance during resistance training
Vandenberghe, K., Goris, M., Van Hecke, P., Van Leemputte, M., Vangerven, L., & Hespel, P. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.2055 · Cited by 430
Creatine in humans with special reference to creatine supplementation
Balsom, P. D., Söderlund, K., & Ekblom, B. (1994) · Sports Medicine · doi:10.2165/00007256-199418040-00005 · Cited by 404
Creatine: Endogenous Metabolite, Dietary, and Therapeutic Supplement
Brosnan, J. T., & Brosnan, M. E. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093621 · Cited by 347
“the progression of visual impairment continued because the hyperornithinemia was not corrected (88).”
Background
Metadata
- Authors
- Vannas-Sulonen, K., Sipilä, I., Vannas, A., Simell, O., & Rapola, J.
- Affiliations
- University of Helsinki (FI)
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 1985-12
- Volume
- 92
- Issue
- 12
- Pages
- 1719-1727
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2087443612
- Cited by
- 124
- References
- 33
- Citations by year
- 2026: 2 · 2025: 1 · 2022: 1 · 2021: 7 · 2018: 1 · 2017: 2 · 2015: 1 · 2014: 3 · 2012: 3
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Ophthalmology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- gyrate atrophy of the choroid and retina, ornithine aminotransferase deficiency, creatine supplementation, chorioretinal degeneration, disease progression, pathogenesis
- MeSH terms
- Adolescent, Adult, Atrophy, Child, Choroid, Creatine, Female, Follow-Up Studies, Humans, Male, Retinal Degeneration, Uveal Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gyrate Atrophy of the Choroid and Retina. https://app.cochat.ai/papers/10.1016/s0161-6420(85)34098-8
- The paper
- Vannas-Sulonen, K., Sipilä, I., Vannas, A., Simell, O., & Rapola, J. (1985). Gyrate Atrophy of the Choroid and Retina. Ophthalmology. https://doi.org/10.1016/s0161-6420(85)34098-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.